The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
Inspection Record
West Penetone Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Critical production processes were not validated.
The written procedures for recalls were inadequate.
The ongoing stability program for a drug was inadequate.
The maintenance of records was inadequate.
The creation, maintenance, processing, and/or review of laboratory data was inadequate. The receipt, preparation, and/or handling of reagents and culture media was inadequate.
The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
The sampling plan for raw materials was inadequate.
The electronic system was not validated for its intended use.
The availability or the content of the authentic certificate of analysis was inadequate.
The handling of standard operating procedures for good manufacturing practices was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-02-21. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
